Cefdipar 300mg Capsule
By Cefdipar
Rx
4 Capsule in a Strip

Composition
Cefdinir(300mg)

Manufacturer - Parenteral Drugs India Ltd
Shree Ganesh Chambers, Navlakha Crossing, A.B. Road, Indore 452001 Mandhya Pradesh (INDIA)

Expires on or after
October, 2025

liver
Cefdipar 300mg Capsule appears to be safe for individuals with liver disease based on the limited information available. There is no strong indication that dosage adjustments are necessary for patients with liver conditions. It is recommended to consult with your doctor regarding the use of Cefdipar 300mg Capsule if you have any liver-related concerns.

kidney
Cefdipar 300mg Capsule requires caution in kidney disease patients. Dose adjustment may be necessary. Consult your doctor.

alcohol
When taking Cefdipar 300mg Capsule, be cautious as it can lead to increased drowsiness when combined with alcohol.

driving
Cefdipar 300mg Capsule may cause decreased alertness, blurred vision, or drowsiness. Avoid driving if experiencing these effects.

pregnancy
Cefdipar 300mg Capsule is considered safe to use during pregnancy based on animal studies showing minimal harm to the baby. Limited human studies available.

breastfeeding
Cefdipar 300mg Capsule is considered safe for breastfeeding mothers. Studies show minimal transfer of the drug to breastmilk, posing no harm to the baby. Use caution to avoid prolonged intake, as it may lead to skin rash or diarrhea.
Habit Forming | No |
Chemical Class | Broad Spectrum (Third & fourth generation cephalosporins) |
Therapeutic Class | ANTI INFECTIVES |
Action Class | Cephalosporins: 3 generation |
₹81.25
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024